EnteroMedics Inc. (Nasdaq: ETRM) reported positive interim results from a 5 year ReCharge Pivotal Trial of VBLOC to treat obesity sending the stock price soaring 87 cents to close at $2.24.
EnteroMedics Reports Positive Interim Data
December 03, 2013 at 17:53 PM EST
